Anticoagulation service

Location

Leicester

Description

The aim of the service is to provide a consistent and high-quality anticoagulant service across Leicester, Leicestershire and Rutland (LLR), that is complimentary to the core primary care services, to ensure the clinical needs of this population are met.

Total Quantity or Scope

The service includes the provision of anticoagulants on a community basis, including provision of: • Near-patient testing • Anticoagulant initiation, patient education and stabilisation. • Anticoagulant prescribing, dosing, and monitoring. • Domiciliary service to housebound patients who require anticoagulation monitoring and are registered with a LLR GP practice. There are 4 contracts with 4 providers to deliver this service across LLR. The intention is to award the contracts via Direct Award C process of The Health Care Services (Provider Selection Regime) Regulations 2023 (the PSR). These are zero-based activity contracts. The dates of the contract will be from the 1 April 2026 to 31 March 2027.

Award Detail

Award Criteria

CPV Codes

• 85140000 - Miscellaneous health services

Indicators

• Award on basis of price and quality.

Legal Justification

This is a Provider Selection Regime (PSR) intention to award notice. The awarding of this contract is subject to the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Procurement Act 2023 do not apply to this award. The standstill period begins on the day after the publication of this notice. Representations by providers must be made to the relevant authority by 23rd March2026. This contract has not yet formally been awarded; this notice serves as an intention to award under the PSR.

Other Information

This is a Provider Selection Regime (PSR) intention to award notice. The awarding of this contract is subject to the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Procurement Act 2023 do not apply to this award. The standstill period begins on the day after the publication of this notice. Representations by providers must be made to decision makers by 23rd March 2026. This contract has not yet formally been awarded; this notice serves as an intention to award under the PSR. - Details of the award decision-makers: NHS LNR ICB cluster Committees Meeting in Common for Finance and Contracting 03 March 2026 - How conflicts or potential conflicts of interest of individuals making the decision were managed: None were declared - Explanation of the relative importance of the PSR's key criteria: • Quality and innovation The reporting requirements and submitted activity are reviewed as part of contract monitoring meetings. There are no quality issues in terms of the providers delivering the services. • Value This service offers value financially and to the local healthcare community as patients continue to access services within a primary care setting across three sites, which reduces demand on more costly services such as ED. The value and benefits of the arrangement with the provider(s) is that they are an experienced provider who understands the needs of these patients, and therefore is able to oversee and understand the service with regard to patient outcomes. These contacts are developed with an annual payment with the terms based on an indicative number of annual (housebound and ambulatory) patients. • Integration, collaboration (improving access) and service sustainability The individual providers have demonstrated an understanding of the needs for specific population. Moreover, this approach of the providers in terms of the integration and collaboration with colleagues and providers in primary and secondary care to provide this service locally for the benefit of their patients remain an important element of the success of this service. • Improving access, reducing health inequalities and facilitating choice An important component of the availability and accessibility of the service is that it is delivered to reflect patients' needs whenever possible, taking account of the general service requirement. • Social value The service supports social value by providing an anticoagulation therapy in a setting that reduces pressure in secondary care and therefore offers environmental gains through reducing patient journeys to manage their healthcare needs.